The more I do broad field research, the more a Morrison deal with Pfizer on 8 April 2021 to strip Viraleze of any chance of success seems to surface. Big pharma controls too much and is hugely profitable and has the necessary influence and contacts/ lobbyists to secure secret favourable outcomes. Then our polis retire and go to work for them or their associates.
I think Starpharma has played the straight bat. Jackie Fairley is in an unenviable innings. Many ready to call them out if they try to cheat - too much critisism on this HC forum too. If a human trial had been organised - it wouldn’t have enough participants❓, it will have Starpharma employees involved❓, it chose a different cohort of partcipants to other competing trials❓, rah rah rah on and on
In a pandemic human trials are verging on useless to show POPULATION TRUTH, maybe we should just go to NOVID Focus groups - that’s what the community engagement consultants do - they abandoned statistics Long ago.
The actual population has changed 2020 to 2023 - so much so that comparative data and measurement are corrupted.
The Scripps mouse trials are much more controlled with the only ethical limitation that mice are euthanised and this means absolutely minimal numbers are used. I just read a very detailed report on that trial which explains far more about the actual science than any placebo controlled in vivo test ever would https://www.mdpi.com/1999-4915/13/8/1656Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
- Forums
- ASX - By Stock
- SPL
- Covid - Vaccine - Viraleze
Covid - Vaccine - Viraleze, page-2
- There are more pages in this discussion • 214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M |
Open | High | Low | Value | Volume |
11.5¢ | 12.0¢ | 11.0¢ | $20.24K | 175.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 267920 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 192261 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 267920 | 0.110 |
10 | 202120 | 0.105 |
12 | 1191472 | 0.100 |
1 | 10305 | 0.097 |
1 | 100000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 192261 | 10 |
0.125 | 698291 | 11 |
0.130 | 319423 | 12 |
0.135 | 75094 | 6 |
0.140 | 103417 | 9 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
11.0¢ |
  |
Change
-0.005 ( 4.35 %) |
|||
Open | High | Low | Volume | ||
11.5¢ | 11.8¢ | 11.0¢ | 32412 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
SPL (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online